The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Head-to-head effectiveness and safety of pembrolizumab plus axitinib vs. nivolumab plus ipilimumab in metastatic renal cell carcinoma in the United States.

Dvir  Aran

Employment - Anthem Inc.; Anthem Israel; Carelon Digital Platforms; Cytoreason; Link Cell Therapies

Speakers' Bureau - CytoReason

Einat  Granot-Hershkovitz

No Relationships to Disclose

Shlomit  Amar-Farkash

Employment - Anthem Inc.

Keren  Rosenberg-Katz

Employment - Carelon Digital Platforms